Navigation Links
Proud Mainers Dedicating Their Professions to Changing Lives Join TideSmart Talk with Stevoe
Date:11/27/2013

FALMOUTH, Maine, Nov. 27, 2013 /PRNewswire/ -- In separate interviews this week with TideSmart Talk with Stevoe, a weekly radio show that takes a macro approach towards society and culture, host Steve Woods was joined by two Mainers who have dedicated their careers to changing lives.   Nobel Peace Prize winner and University of Maine graduate, Dr. Bernard Lown and executive director of Preble Street, Mark Swann discussed how it is morally imperative to be the change you wish to see in the world.

The show will air Saturday, November 30, from 11:00 a.m. – 1:00 p.m. on News Talk WLOB 1310AM and will be live streamed at http://www.wlobradio.com.  A podcast will be made available via iTunes and at http://www.tidesmartradio.com.  In the show's first hour, Woods, who is also President/CEO of Tidesmart Global, was joined by the world-renowned Dr. Bernard Lown, Founder and Chairman Emeritus of The Lown Institute, developer of the defibrillator, a Gandhi Peace Prize winner, Nobel Peace Prize winner and University of Maine graduate.  

During the show's opening segment, Woods and Lown talked about the development and the technology of the DC defibrillator, and how it has been life changing all around the globe.  Lown also discussed his work co-founding SatelLife and ProCor, as well as the International Physicians for the Prevention of Nuclear War (IPPNW), for which Lown won the Nobel Peace Prize in 1985.  The threat of nuclear war is no longer our biggest concern, Lown said.

"Climate change now is bigger than nuc
'/>"/>

SOURCE TideSmart
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. UBM Canon and MD+DI Proudly Announce 27 Innovative Products as Winners of the 2013 Medical Design Excellence Awards
2. Healthcare Tech developers ENuke Software LLC proud to announce completion of eBroselowLutens Artemis in Dutch, German, Portugese and Spanish
3. UBM Canon and MD+DI Proudly Announce 25 Innovative Products as Winners of the 2012 Medical Design Excellence Awards
4. UCB Proudly Reinforces Long-Standing Commitment to Crohns Disease Community at Digestive Disease Week 2012
5. Two-Thirds of Surveyed U.S. Neurologists Have Prescribed Genzymes Aubagio to Their Multiple Sclerosis Patients at One Year Post-Launch
6. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
7. Surveyed EU5 Rheumatologists Prescribe Biologics to Approximately Half of Their DMARD-Treated Psoriatic Arthritis Patients
8. MBA students eye Rutgers Business Schools biopharmaceutical case competition as a chance to demonstrate their knowledge of the pharmaceutical business and make valuable connections.
9. 2014 Medicare Drug Plans Vary Widely in Availability of Drugs and Restrictions on Their Use
10. Langland Collaboration with CISCRP to Show Participants How Their Words Can Impact a Clinical Trial
11. Postscript to Sundays Falls Prevention Awareness Day: Make Seniors Aware They Can Protect Their Hips If They Fall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
(Date:1/14/2014)... Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre partner ... Virginia is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is ... husband, Dr. Cole Taylor , are avid scuba divers. "As ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
... Center is,seeking local residents with type 2 diabetes ... study evaluating an investigational,device, the TANTALUS System. Diabetes ... TANTALUS System is an implantable device that delivers ... The primary objective of the,randomized, double-blind controlled study ...
... successfully targets human leukemic stem cells, ATLANTA, ... has today presented data at the American Society,of ... promising,pre-clinical activity of a novel monoclonal antibody, in ... AML is an aggressive cancer of white blood ...
Cached Medicine Technology:Vanderbilt Medical Center Seeks Middle Tennesseans with Type 2 Diabetes Who are Overweight for National Clinical Trial 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 3
(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
... of Western Ontario has received over $603,000 from the Canadian ... a group of bacterial toxins leads to the development of ... is an associate professor in the Department of Microbiology and ... a scientist with the Lawson Health Research Institute. His ...
... (UV) radiation from sunlight may be associated with the ... to a study by researchers at the National Institute ... Institutes of Health. "This study found that women ... exposure when they developed an autoimmune muscle disease called ...
... July 30, 2009 Scientists at Washington University School ... in the liver that helps process fat and glucose. ... additive lecithin, and researchers speculate it may one day ... lipids and reduce risk for diabetes, hypertension or cardiovascular ...
... , , , ... $230,000 for Augie,s Quest, the fast-track research arm of the Muscular Dystrophy ... is dedicated to beating the previous goal by reaching $300,000 in donations ... Bally club now through August 31 and receive a free guest pass ...
... more apt to have joint replacement, study finds , THURSDAY, ... strongly predict the risk of hip and knee joint replacement ... , The research involved 912 healthy people in Italy, including ... or hip replacement between 1990 and 2005. Those with high ...
... , , , ... Mark Rodgers today announced that The Guardian House Alzheimer Care Facility ... commercial location to install the SamarionSolution, The Guardian House is a ... in caring for residents diagnosed with Alzheimer,s or dementia. The ...
Cached Medicine News:Health News:Sun exposure may trigger certain autoimmune diseases in women 2Health News:Food additive may one day help control blood lipids and reduce disease risk 2Health News:Food additive may one day help control blood lipids and reduce disease risk 3Health News:Bally Total Fitness Flexes Fundraising Muscle to Fight ALS 2Health News:Biomarker Could Predict Severe Osteoarthritis 2Health News:The First SamarionSolution Installed in Lake Charles Alzheimer's Facility 2
... An ISI technician carefully inspects your equipment ... any and all problems, and provides you with ... may be working within a tight budget so ... the intricate work of repair begins., , ISI ...
... ALT (GPT) powder reagent is intended for ... in serum. , Infinity ALT (GPT) powder ... stability once reconstituted and convenience, but ensures ... The reagent is suitable for manual use ...
... is a fully automated, versatile analyzer ... is increased due to the continuous loading ... A fully graphical user interface provides fast ... use. Konelab analyzers are delivered with full ...
Inquire...
Medicine Products: